Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy
- PMID: 27576553
- DOI: 10.1159/000448118
Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy
Abstract
Background: The prognosis of combined cases of pulmonary fibrosis and emphysema is unresolved partially because radiological differentiation between usual interstitial pneumonia and nonspecific interstitial pneumonia is difficult in coexisting emphysema cases.
Objective: The purpose of this study was to clarify the clinical impact of emphysema on the survival of patients with idiopathic pulmonary fibrosis (IPF).
Methods: One hundred and seven patients with interstitial lung diseases were diagnosed by surgical lung biopsies between 2006 and 2012, and 47 patients were diagnosed with IPF through multidisciplinary discussion. Emphysema on high-resolution computed tomography scans was evaluated semiquantitatively by visual scoring.
Results: Eight out of the 47 IPF patients showed a higher emphysema score (>3) and were diagnosed to have IPF-emphysema. The median survival time of patients with IPF-emphysema (1,734 days) from the initial diagnosis was significantly shorter than that of patients with IPF alone (2,229 days) by Kaplan-Meier analysis (p = 0.007, log-rank test). Univariate Cox proportional hazard regression analyses revealed that a higher total emphysema score (>3.0) was a significantly poor prognostic factor in addition to Krebs von den Lungen-6, surfactant protein-D, arterial oxygen tension, percent forced vital capacity, and percent diffusing capacity of carbon monoxide (%DLCO). Multivariate Cox proportional hazard regression analyses with the stepwise method showed that higher total emphysema score (>3) and %DLCO were significantly poor prognostic factors.
Conclusions: The prognosis of IPF-emphysema was significantly worse than that of IPF alone.
© 2016 S. Karger AG, Basel.
Comment in
-
Idiopathic Pulmonary Fibrosis and Emphysema: Between Scylla and Charybdis.Respiration. 2016;92(4):215-217. doi: 10.1159/000448850. Epub 2016 Sep 8. Respiration. 2016. PMID: 27603927 No abstract available.
Similar articles
-
The predictors of mortality in IPF - Does emphysema change the prognosis?Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):267-274. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27758993
-
Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.Respir Med. 2013 Nov;107(11):1781-8. doi: 10.1016/j.rmed.2013.08.039. Epub 2013 Sep 3. Respir Med. 2013. PMID: 24051272
-
Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.Eur Respir J. 2017 Jul 5;50(1):1700379. doi: 10.1183/13993003.00379-2017. Print 2017 Jul. Eur Respir J. 2017. PMID: 28679612
-
The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.Chron Respir Dis. 2019 Jan-Dec;16:1479973119867945. doi: 10.1177/1479973119867945. Chron Respir Dis. 2019. PMID: 31387379 Free PMC article. Review.
-
Pulmonary hypertension in chronic lung diseases.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
Cited by
-
Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone.Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619888119. doi: 10.1177/1753466619888119. Ther Adv Respir Dis. 2019. PMID: 31722622 Free PMC article.
-
Comorbidities and Complications in Idiopathic Pulmonary Fibrosis.Med Sci (Basel). 2018 Aug 30;6(3):71. doi: 10.3390/medsci6030071. Med Sci (Basel). 2018. PMID: 30200249 Free PMC article. Review.
-
The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.Front Med (Lausanne). 2019 Oct 31;6:246. doi: 10.3389/fmed.2019.00246. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31750308 Free PMC article.
-
The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases.Diagnostics (Basel). 2023 Jul 21;13(14):2437. doi: 10.3390/diagnostics13142437. Diagnostics (Basel). 2023. PMID: 37510180 Free PMC article. Review.
-
Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation, and mortality in interstitial lung disease: a systematic review and meta-analysis.Front Immunol. 2025 Feb 14;16:1450798. doi: 10.3389/fimmu.2025.1450798. eCollection 2025. Front Immunol. 2025. PMID: 40028331 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous